![]() |
|
|
Vol. 293, Issue 3, 705-709, June 2000
Departments of Pharmacology and Chemistry, The Fiske Drug Discovery
Laboratory and The Combinatorial Chemistry Center, University of
Pittsburgh, Pittsburgh, Pennsylvania
Both solid- and liquid-phase combinatorial chemistry have emerged as
powerful tools for identifying pharmacologically active compounds and
optimizing the biological activity of a lead compound. Complementary
high-throughput in vitro assays are essential for compound evaluation.
Cell-based assays that use optical endpoints permit investigation of a
wide variety of functional properties of these compounds including
specific intracellular biochemical pathways, protein-protein
interactions, and the subcellular localization of targets. Integration
of combinatorial chemistry with contemporary pharmacology now
represents an important factor in drug discovery and development.
This article has been cited by other articles:
![]() |
B. A. Grzybowski, A. V. Ishchenko, C.-Y. Kim, G. Topalov, R. Chapman, D. W. Christianson, G. M. Whitesides, and E. I. Shakhnovich Combinatorial computational method gives new picomolar ligands for a known enzyme PNAS, January 24, 2002; (2002) 32673399. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Bumol and A. M. Watanabe Genetic Information, Genomic Technologies, and the Future of Drug Discovery JAMA, February 7, 2001; 285(5): 551 - 555. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Grzybowski, A. V. Ishchenko, C.-Y. Kim, G. Topalov, R. Chapman, D. W. Christianson, G. M. Whitesides, and E. I. Shakhnovich Combinatorial computational method gives new picomolar ligands for a known enzyme PNAS, February 5, 2002; 99(3): 1270 - 1273. [Abstract] [Full Text] [PDF] |
||||